Anumana Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 163

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $95.4M

  • Investors
  • 8

Anumana General Information

Description

Developer of an AI-driven medical technology designed to enhance early diagnosis and intervention in cardiovascular care. The company's platform integrates algorithms with existing clinical workflows, facilitating the transformation of unstructured data into actionable insights, enabling healthcare providers to identify hidden cardiovascular diseases early and improve patient outcomes through timely interventions.

Contact Information

Website
www.anumana.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • One Main Street, 4th Floor
  • Suite 400 East Arcade
  • Cambridge, MA 02142
  • United States
+1 (800)
Primary Industry
Decision/Risk Analysis
Vertical(s)
Big Data, Digital Health, SaaS, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • One Main Street, 4th Floor
  • Suite 400 East Arcade
  • Cambridge, MA 02142
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anumana Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC 27-Mar-2025 $95.4M Completed Product Development
5. Accelerator/Incubator 01-Jun-2022 Completed Product Development
4. Early Stage VC (Series B) 09-Jun-2021 Completed Product Development
3. Early Stage VC (Series A) 14-Apr-2021 Completed Product Development
2. Seed Round $4.2M $4.2M Completed Product Development
1. Joint Venture 14-Apr-2021 Completed Product Development
To view Anumana’s complete valuation and funding history, request access »

Anumana Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C
Series B
Series A 25,700,000 $0.001000 $1 $1 1x $1 22.88%
Seed 21,000,000 $0.001000 $0.2 $0.2 1x $0.2 18.7%
To view Anumana’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Anumana Patents

  • 238

    Total Documents Applications and Grants

  • Total Patents Families

  • 130

    Granted

  • 92

    Pending

  • Expiring in next 12 mo

Anumana Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260345114-A1 System and method for sweep trajectory simulation Pending 16-Jul-2026
US-12708457-B1 Apparatus and method for localization associated with aortic valve repair using transesophageal echocardiography Active 11-Aug-2025
US-12755846-B1 Systems and methods for generating diagnostic information as a function of an electrocardiogram signal Active 17-Jul-2025
US-12505551-B1 Apparatus and method for automatically extracting canonical views from ultrasound imaging data Active 28-Jun-2025
US-12575808-B1 Systems and methods for guiding ultrasonic probe positioning using scoring-based canonical view simulation model Active 28-Jun-2025 A61B6/03
To view Anumana’s complete patent history, request access »

Anumana Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anumana Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Boston Scientific Corporation Minority
MedTech Innovator Accelerator/Incubator Minority
Mayo Clinic Ventures Corporate Venture Capital Minority
Matrix Venture Capital Minority
Matrix Capital Management Hedge Fund Minority
You’re viewing 5 of 8 investors. Get the full list »

Anumana Acquisitions (1)

Anumana’s most recent deal was a Merger/Acquisition with NeuCures. The deal was made on 07-Nov-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
NeuCures 07-Nov-2022 Merger/Acquisition Decision/Risk Analysis
To view Anumana’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Anumana Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
NeuCures Marina Del Rey, CA 2017

Anumana FAQs

  • When was Anumana founded?

    Anumana was founded in 2021.

  • Where is Anumana headquartered?

    Anumana is headquartered in Cambridge, MA.

  • What is the size of Anumana?

    Anumana has 163 total employees.

  • What industry is Anumana in?

    Anumana’s primary industry is Decision/Risk Analysis.

  • Is Anumana a private or public company?

    Anumana is a Private company.

  • What is the current valuation of Anumana?

    The current valuation of Anumana is .

  • What is Anumana’s current revenue?

    The current revenue for Anumana is .

  • How much funding has Anumana raised over time?

    Anumana has raised $185M.

  • Who are Anumana’s investors?

    Boston Scientific, MedTech Innovator, Mayo Clinic Ventures, Matrix, and Matrix Capital Management are 5 of 8 investors who have invested in Anumana.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process